DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Yes. Switching from Wegovy (semaglutide) to Zepbound (tirzepatide) is supported when Wegovy intolerance, plateau, or coverage loss occurs. Restart titration at Zepbound 2.5mg.
Switching from Wegovy to Zepbound is increasingly common in 2026. Reasons include: Wegovy intolerance (severe GI side effects), weight loss plateau, or insurance coverage loss for Wegovy. Wait one week after final Wegovy dose, then start Zepbound at 2.5mg starter and titrate over 4-week intervals. SURMOUNT-1 trial showed Zepbound delivers ~22% body weight loss vs Wegovy ~15% in SELECT. The OSA-with-obesity FDA indication (December 2024) made Zepbound easier to approve on plans that previously denied weight-loss tirzepatide. LillyDirect cash-pay at $549/month is a backup if insurance denies.
Editorial answer reviewed by a board-certified clinician. Not medical advice. Coordinate treatment decisions with your prescriber.